New dual defense tested to shield babies from malaria
NCT ID NCT06461026
Summary
This study is testing a one-time antibody injection (L9LS) to see if it is safe for infants and if it interferes with a later malaria vaccine. It involves 180 healthy infants in Mali, aged 1 to 12 months. Researchers will give some infants the antibody and others a placebo, then later give all infants the standard malaria vaccine to compare their immune responses and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faladje MRTC Clinic
Faladié, Koulikoro, Mali
-
Kalifabougou MRTC Clinic
Kalifabougou, Koulikoro, Mali
-
Torodo MRTC Clinic
Torodo, Koulikoro, Mali
Conditions
Explore the condition pages connected to this study.